Bionano Announces 4-Day 2026 OGM Symposium

Global experts to showcase advances and innovation in optical genome mapping technology

Published on Feb. 9, 2026

Got story updates? Submit your updates here. ›

Bionano Genomics, Inc. announced Bionano Symposium 2026, a virtual event that will bring together leading scientists from around the world to present cutting-edge findings and share insights into emerging applications of optical genome mapping (OGM) technology. The four-day symposium, taking place from February 23-26, 2026, will feature presentations from over 30 researchers covering research in hematologic malignancies, solid tumors, bioprocessing, constitutional genetic disorders, and gene and cell therapy.

Why it matters

The Bionano Symposium 2026 provides a unique platform for the global OGM community to share real-world experiences and demonstrate how OGM can reveal genomic complexity that is difficult to detect with conventional technologies. The event highlights the expanding role of OGM in various fields, including oncology research, constitutional genetics, and bioprocessing, showcasing how researchers worldwide are advancing genome analysis through innovative applications of OGM.

The details

The four-day virtual symposium will feature presentations, interactive panel discussions with Q&A, and a virtual poster hall. Each session will begin at 7:00 AM PST and last approximately three hours, covering topics such as advancements in hematologic malignancies, new frontiers in oncology research and bioprocessing applications, OGM's use in constitutional genetic disorder research, and a deep dive into Bionano's product lineup, including the Ionic, Saphyr, and Stratys systems, and VIA software.

  • The Bionano Symposium 2026 will take place from February 23-26, 2026.
  • Each session will begin at 7:00 AM PST and last approximately three hours.

The players

Bionano Genomics, Inc.

A provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine.

Erik Holmlin

President and chief executive officer of Bionano Genomics, Inc.

Alka Chaubey, PhD, FACMG

Chief medical officer at Bionano Genomics, Inc.

Got photos? Submit your photos here. ›

What they’re saying

“At Bionano, we are transforming the way the world sees the genome. Our Symposium brings together the global OGM community to share real-world experiences and demonstrate how OGM can reveal genomic complexity that is difficult to detect with conventional technologies.”

— Erik Holmlin, President and chief executive officer (Bionano Genomics, Inc.)

“The 2026 Symposium will showcase how researchers worldwide are advancing genome analysis through innovative applications of OGM and establishing it as a cornerstone tool for modern cytogenetic and genome analysis.”

— Alka Chaubey, PhD, FACMG, Chief medical officer (Bionano Genomics, Inc.)

What’s next

Registration for the Bionano Symposium 2026 is free and open to all. Researchers can also submit their posters to be showcased at the virtual event.

The takeaway

The Bionano Symposium 2026 highlights the growing importance and diverse applications of optical genome mapping technology in various fields, including oncology, genetics, and bioprocessing. The event provides a platform for the global OGM community to share their latest findings and innovations, further advancing the use of this transformative technology in research and clinical settings.